Third-generation antidepressants - Do they offer advantages over the SSRIs?

被引:54
作者
Olver, JS [1 ]
Burrows, GD [1 ]
Norman, TR [1 ]
机构
[1] Univ Melbourne, Dept Psychiat, Austin & Repatriat Med Ctr, Heidelberg West, Vic 3081, Australia
关键词
D O I
10.2165/00023210-200115120-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Third-generation antidepressants are a group of antidepressant agents of variable action, not confined to serotonin reuptake inhibition. These agents include venlafaxine, reboxetine, nefazodone and mirtazapine. Claims have been made for these agents in terms of improved efficacy, faster speed of onset of effect and greater safety in the treatment of depression compared with previous medications, such as the selective serotonin reuptake inhibitors (SSRIs). This article reviews the evidence for these improvements. Thirty active comparator studies were reviewed involving the third-generation antidepressant agents. While there were isolated reports of improvements over comparator agents for venlafaxine, reboxetine and mirtazepine, there were no convincing differences between third-generation agents and comparators in terms of overall efficacy, relapse prevention and speed of onset. The third-generation antidepressants were, however, of equivalent safety to SSRIs and maintained improvements in safety over first-generation agents.
引用
收藏
页码:941 / 954
页数:14
相关论文
共 85 条
  • [1] ANGST J, 1992, PERSPECT PSYCHIATR C, V3, P1
  • [2] ANTON SF, 1994, PSYCHOPHARMACOL BULL, V30, P165
  • [3] Nefazodone-induced liver failure: Report of three cases
    Aranda-Michel, J
    Koehler, A
    Bejarano, PA
    Poulos, JE
    Luxon, BA
    Khan, CM
    Ee, LC
    Balistreri, WF
    Weber, FL
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (04) : 285 - 288
  • [4] Baldwin DS, 1996, J CLIN PSYCHIAT, V57, P46
  • [5] Baldwin DS, 2000, REV CONTEMP PHARMACO, V11, P321
  • [6] The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia
    Ballús, C
    Quiros, G
    de Flores, T
    de la Torre, J
    Palao, D
    Rojo, L
    Gutiérrez, M
    Casais, L
    Riesgo, Y
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (01) : 43 - 48
  • [7] Ban TA, 1998, HUM PSYCHOPHARM CLIN, V13, pS29, DOI 10.1002/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.3.CO
  • [8] 2-4
  • [9] COADMINISTRATION OF NEFAZODONE AND BENZODIAZEPINES .2. A PHARMACOKINETIC INTERACTION STUDY WITH TRIAZOLAM
    BARBHAIYA, RH
    SHUKLA, UA
    KROBOTH, PD
    GREENE, DS
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (05) : 320 - 326
  • [10] Fatal venlafaxine overdose
    Benham, NDG
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (08) : 445 - +